These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24067139)
1. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma. Valencia-Hipόlito A; Hernández-Atenógenes M; Vega GG; Maldonado-Valenzuela A; Ramon G; Mayani H; Peña Alonso Y; Martinez-Maza O; Méndez-Tenorio A; Huerta-Yepez S; Bonavida B; Vega MI Leuk Lymphoma; 2014 Aug; 55(8):1806-14. PubMed ID: 24067139 [TBL] [Abstract][Full Text] [Related]
2. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia]. Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397 [TBL] [Abstract][Full Text] [Related]
3. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study. Xiao J; Du S; Dai G; Gao G; Yang D; Zhao H Sci Rep; 2017 May; 7(1):1905. PubMed ID: 28507339 [TBL] [Abstract][Full Text] [Related]
5. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma. Frick M; Dörken B; Lenz G Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819 [TBL] [Abstract][Full Text] [Related]
6. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma. Nomura Y; Yoshida S; Karube K; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K Cancer Sci; 2008 Aug; 99(8):1564-9. PubMed ID: 18754867 [TBL] [Abstract][Full Text] [Related]
7. Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases. Zhang S; Wilson D; Czader M Ann Lab Med; 2015 Mar; 35(2):254-6. PubMed ID: 25729731 [No Abstract] [Full Text] [Related]
8. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas. Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819 [TBL] [Abstract][Full Text] [Related]
9. Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience. Chauhan P; Gupta A; Mandelia A; Yadav S; Rahman K; Nityanand S Pediatr Hematol Oncol; 2021 May; 38(4):305-318. PubMed ID: 33646922 [TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients. Koh YW; Hwang HS; Park CS; Yoon DH; Suh C; Huh J Leuk Lymphoma; 2015; 56(9):2630-6. PubMed ID: 25573205 [TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological and molecular genetic characteristics of childhood diffuse large B cell lymphoma]. Huang H; Yang WP; Xu HY Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):209-11. PubMed ID: 22780976 [No Abstract] [Full Text] [Related]
13. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. Bowman WP; Shuster JJ; Cook B; Griffin T; Behm F; Pullen J; Link M; Head D; Carroll A; Berard C; Murphy S J Clin Oncol; 1996 Apr; 14(4):1252-61. PubMed ID: 8648381 [TBL] [Abstract][Full Text] [Related]
14. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Sandlund JT; Fonseca T; Leimig T; Verissimo L; Ribeiro R; Lira V; Berard CW; Sixbey J; Crist WM; Mao L; Chen G; Pui CH; Heim M; Pedrosa F Leukemia; 1997 May; 11(5):743-6. PubMed ID: 9180301 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan. Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129 [TBL] [Abstract][Full Text] [Related]
16. How I treat Burkitt lymphoma in adults. Jacobson C; LaCasce A Blood; 2014 Nov; 124(19):2913-20. PubMed ID: 25258344 [TBL] [Abstract][Full Text] [Related]
17. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol. Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319 [TBL] [Abstract][Full Text] [Related]
19. Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center. Tanyildiz HG; Dincaslan H; Yavuz G; Unal E; Ikinciogulları A; Dogu F; Tacyildiz N J Clin Immunol; 2016 Oct; 36(7):667-76. PubMed ID: 27492260 [TBL] [Abstract][Full Text] [Related]
20. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma]. Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]